- Home
- ATNM vs CYN Comparison
ATNM vs CYN Comparison
Compare ATNM & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- CYN
- Stock Information
- Founded
- ATNM 2000
- CYN 2013
- Country
- ATNM United States
- CYN United States
- Employees
- ATNM N/A
- CYN N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- CYN EDP Services
- Sector
- ATNM Health Care
- CYN Technology
- Exchange
- ATNM Nasdaq
- CYN Nasdaq
- Market Cap
- ATNM 50.2M
- CYN 42.0M
- IPO Year
- ATNM N/A
- CYN 2021
- Fundamental
- Price
- ATNM $1.29
- CYN $4.02
- Analyst Decision
- ATNM Strong Buy
- CYN
- Analyst Count
- ATNM 2
- CYN 0
- Target Price
- ATNM $4.50
- CYN N/A
- AVG Volume (30 Days)
- ATNM 306.1K
- CYN 1.6M
- Earning Date
- ATNM 11-14-2025
- CYN 11-05-2025
- Dividend Yield
- ATNM N/A
- CYN N/A
- EPS Growth
- ATNM N/A
- CYN N/A
- EPS
- ATNM N/A
- CYN N/A
- Revenue
- ATNM N/A
- CYN $434,837.00
- Revenue This Year
- ATNM N/A
- CYN $31.96
- Revenue Next Year
- ATNM N/A
- CYN $1,459.25
- P/E Ratio
- ATNM N/A
- CYN N/A
- Revenue Growth
- ATNM N/A
- CYN 445.29
- 52 Week Low
- ATNM $1.03
- CYN $3.62
- 52 Week High
- ATNM $2.41
- CYN $1,312.50
- Technical
- Relative Strength Index (RSI)
- ATNM 40.17
- CYN 32.75
- Support Level
- ATNM $1.23
- CYN $3.80
- Resistance Level
- ATNM $1.40
- CYN $4.47
- Average True Range (ATR)
- ATNM 0.09
- CYN 0.30
- MACD
- ATNM -0.01
- CYN -0.04
- Stochastic Oscillator
- ATNM 19.61
- CYN 15.50
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About CYN Cyngn Inc.
Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.